UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer

Frontiers in immunology, 2022-12, Vol.13, p.1058424-1058424

2022

Volltextzugriff (PDF)

Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma

Cancers, 2023-10, Vol.15 (20), p.4952

2023

Volltextzugriff (PDF)

Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer

Cancers, 2022-09, Vol.14 (19), p.4561

2022

Volltextzugriff (PDF)

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

PloS one, 2021-02, Vol.16 (2), p.e0246958-e0246958

2021

Volltextzugriff (PDF)

Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas

Modern pathology, 2015-11, Vol.28 (11), p.1404-1414

2015

Volltextzugriff (PDF)

Localised angiosarcomas: The identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

European journal of cancer (1990), 2013-01, Vol.49 (2), p.369-376

2013

Volltextzugriff (PDF)

Pleomorphic liposarcoma : Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: A study from the French Federation of Cancer Centers Sarcoma Group

The American journal of surgical pathology, 2002-05, Vol.26 (5), p.601-616

2002

Volltextzugriff (PDF)

The Non-Crosslinking Fixative RCL2®-CS100 is Compatible with Both Pathology Diagnosis and Molecular Analyses

Pathology oncology research, 2013, Vol.19 (1), p.41-53

2013

Volltextzugriff (PDF)

Quelle prise en charge chirurgicale pour « les lésions à haut risque » de cancer du sein ?

Bulletin du cancer, 2014-07, Vol.101 (7-8), p.718-729

2014

Volltextzugriff (PDF)

Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett’s oesophagus: report of a case with a favourable behaviour

Virchows Archiv : an international journal of pathology, 2008, Vol.452 (1), p.103-107

2008

Volltextzugriff (PDF)

Variation d’expression des récepteurs hormonaux et d’HER-2 dans l’évolution du cancer du sein : quelles implications en pratique clinique ?

Bulletin du cancer, 2011-09, Vol.98 (9), p.1059-1070

2011

Volltextzugriff (PDF)

Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk : A study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas

The American journal of surgical pathology, 2007-10, Vol.31 (10), p.1557-1566

2007

Volltextzugriff (PDF)

Abstract P2-11-17: Prognostic value of Trop2 expression levels in non-metastatic triple-negative breast cancer and correlation with other biomarkers

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-11-17

2023

Volltextzugriff (PDF)

Une métastase hépatique d’aspect particulier

Annales de pathologie, 2006, Vol.26 (6), p.455-456

2006

Volltextzugriff (PDF)

Hafnium oxide nanoparticle activated by radiotherapy to generate an anti-tumor immune response

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15149-e15149

2018

Volltextzugriff (PDF)

Localized angiosarcomas (AS): Identification of prognostic factors (PF) and analysis of treatment impact—Series from the French Sarcoma Group (GSF/GETO)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10018-10018

2012

Volltextzugriff (PDF)

Breast surgeon role in the management of high-risk breast lesions

Bulletin du cancer, 2014-07, Vol.101 (7-8), p.718

2014

Volltextzugriff (PDF)

Hormone receptors and HER-2 changes during breast cancer progression: clinical implications

Bulletin du cancer, 2011-10, Vol.98 (9), p.1059

2011

Volltextzugriff (PDF)

Neoadjuvant treatment of breast cancer: implications for the pathologist

Annales de pathologie, 2011-12, Vol.31 (6), p.442-454

2011

Volltextzugriff (PDF)

Place du pathologiste dans la prise en charge néoadjuvante des cancers du sein

Annales de pathologie, 2011-12, Vol.31 (6), p.442-454

2011

Volltextzugriff (PDF)

Place du pathologiste dans la prise en charge néoadjuvante des cancers du sein: Place du pathologiste dans la prise en charge des cancers en situation néoadjuvante

Annales de pathologie, 2011, Vol.31 (6), p.442-454

2011

Volltextzugriff (PDF)

An unusual liver metastasis

Annales de pathologie, 2006-12, Vol.26 (6), p.455-456

2006

Volltextzugriff (PDF)

Prise en charge des lésions mammaires infra-cliniques par macrobiopsies assistées par le vide (procédure Mammotome®) : Expérience du Centre Val d'Aurelle à propos d'une série de 560 procédures: Un numéro spécial de pathologie mammaire

Annales de pathologie, 2003, Vol.23 (6), p.582-592

2003

Volltextzugriff (PDF)

Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center

Annales de pathologie, 2003-12, Vol.23 (6), p.582-592

2003

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(41)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer

Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma

Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas

A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer

Localised angiosarcomas: The identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

Pleomorphic liposarcoma : Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: A study from the French Federation of Cancer Centers Sarcoma Group

The Non-Crosslinking Fixative RCL2®-CS100 is Compatible with Both Pathology Diagnosis and Molecular Analyses

Quelle prise en charge chirurgicale pour « les lésions à haut risque » de cancer du sein ?

Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett’s oesophagus: report of a case with a favourable behaviour

Variation d’expression des récepteurs hormonaux et d’HER-2 dans l’évolution du cancer du sein : quelles implications en pratique clinique ?

Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk : A study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas

Abstract P2-11-17: Prognostic value of Trop2 expression levels in non-metastatic triple-negative breast cancer and correlation with other biomarkers

Une métastase hépatique d’aspect particulier

Hafnium oxide nanoparticle activated by radiotherapy to generate an anti-tumor immune response

Localized angiosarcomas (AS): Identification of prognostic factors (PF) and analysis of treatment impact—Series from the French Sarcoma Group (GSF/GETO)

Breast surgeon role in the management of high-risk breast lesions

Hormone receptors and HER-2 changes during breast cancer progression: clinical implications

Neoadjuvant treatment of breast cancer: implications for the pathologist

Place du pathologiste dans la prise en charge néoadjuvante des cancers du sein

Place du pathologiste dans la prise en charge néoadjuvante des cancers du sein: Place du pathologiste dans la prise en charge des cancers en situation néoadjuvante

An unusual liver metastasis

Prise en charge des lésions mammaires infra-cliniques par macrobiopsies assistées par le vide (procédure Mammotome®) : Expérience du Centre Val d'Aurelle à propos d'une série de 560 procédures: Un numéro spécial de pathologie mammaire

Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center

Suchergebnisse filtern